Magda Alexis

784 total citations
9 papers, 57 citations indexed

About

Magda Alexis is a scholar working on Pathology and Forensic Medicine, Hematology and Genetics. According to data from OpenAlex, Magda Alexis has authored 9 papers receiving a total of 57 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 3 papers in Hematology and 2 papers in Genetics. Recurrent topics in Magda Alexis's work include Lymphoma Diagnosis and Treatment (6 papers), Acute Lymphoblastic Leukemia research (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Magda Alexis is often cited by papers focused on Lymphoma Diagnosis and Treatment (6 papers), Acute Lymphoblastic Leukemia research (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Magda Alexis collaborates with scholars based in France and United States. Magda Alexis's co-authors include Rémy Gressin, Steven Le Gouill, Thomas Cluzeau, Thibaut Leguay, Diane Damotte, T. Lamy, Vincent Delwail, Nicolas Boissel, Marie Balsat and Hervé Dombret and has published in prestigious journals such as Blood, British Journal of Haematology and Haematologica.

In The Last Decade

Magda Alexis

8 papers receiving 56 citations

Peers

Magda Alexis

ONCOL

PFM

PHEOH

HEMAT

GENET

Sandra Le Guyader-Peyrou France

Francisco Lastiri Argentina

G.K. Bascom United States

Thomas Creasey United Kingdom

Amanda Gillespie-Twardy United States

Gavin Preston United Kingdom

Yuka Iijima‐Yamashita Japan

Pegah Farrokhi Iran

Rathana Kim France

Simon Rule United Kingdom

Sandra Le Guyader-Peyrou France

Magda Alexis

40 ×1.1

ONCOL

56 ×1.7

PFM

17 ×0.7

PHEOH

9 ×0.5

HEMAT

33 ×2.2

GENET

Citations per year, relative to Magda Alexis Magda Alexis (= 1×) peers Sandra Le Guyader-Peyrou

Countries citing papers authored by Magda Alexis

Since Specialization

Citations

This map shows the geographic impact of Magda Alexis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magda Alexis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magda Alexis more than expected).

Fields of papers citing papers by Magda Alexis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magda Alexis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magda Alexis. The network helps show where Magda Alexis may publish in the future.

Co-authorship network of co-authors of Magda Alexis

This figure shows the co-authorship network connecting the top 25 collaborators of Magda Alexis. A scholar is included among the top collaborators of Magda Alexis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magda Alexis. Magda Alexis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Cabannes‐Hamy, Aurélie, Éolia Brissot, Thibaut Leguay, et al.. (2022). High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL. Haematologica. 107(9). 2072–2080. 24 indexed citations

Beauvais, David, Aurélie Cabannes‐Hamy, Thierry Leblanc, et al.. (2020). T-Cell Acute Lymphoblastic Leukemia in a Young Adult With Thrombocytopenia-absent Radius Syndrome: A Case Report and Review of the Literature. Journal of Pediatric Hematology/Oncology. 43(6). 232–235.

Cornillon, Jérôme, Élisabeth Daguenet, Jacques‐Olivier Bay, et al.. (2019). BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC). Annals of Hematology. 98(8). 1973–1980. 1 indexed citations

Groh, Matthieu, Guillaume Lefèvre, Magda Alexis, et al.. (2019). Efficacy and Tolerance of Interferon-α in Hypereosinophilic Syndromes. a Retrospective Multicenter Study on 29 Patients. Blood. 134(Supplement_1). 2322–2322. 1 indexed citations

Dubreuil, Julien, Roch Houot, Steven Le Gouill, et al.. (2014). Long Term Results of a Multicenter Prospective Trial By the Lysa Group Evaluating the RiPAD+C Regimen (Combination of Rituximab, Bortezomib, Doxorubicin, Dexamethasone and Chlorambucil) As First-Line Therapy for Elderly Mantle Cell Lymphoma Patients (MCL): Prognostic Value of FDG-PET/CT. Blood. 124(21). 3070–3070. 1 indexed citations

Kerdraon, R., et al.. (2013). Syndrome d’activation macrophagique révélant un lymphome anaplasique à grandes cellules de variante lymphohistiocytaire : à propos d’un cas. Annales de Pathologie. 33(4). 278–282. 1 indexed citations

Gyan, Emmanuel, Diane Damotte, Delphine Sénécal, et al.. (2013). High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B‐cell lymphoma in first relapse: results of the R‐NIMP GOELAMS study. British Journal of Haematology. 162(2). 240–249. 13 indexed citations

Milpied, Nöel, Steven Le Gouill, Thierry Lamy, et al.. (2010). No Benefit of First-Line Rituximab (R) - High-Dose Therapy (R-HDT) Over R-CHOP14 for Young Adults with Diffuse Large B-Cell Lymphoma. Preliminary Results of the GOELAMS 075 Prospective Multicentre Randomized Trial. Blood. 116(21). 685–685. 13 indexed citations

Gressin, Rémy, Roch Houot, Mario Ojeda‐Uribe, et al.. (2010). Final Results of the RiPAD+C Regimen Including Velcade In Front Line Therapy for Elderly Patients with Mantle Cell Lymphoma. A Phase II Prospective Study of the GOELAMS Group.. Blood. 116(21). 2791–2791. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact